economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Licensing

Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment OG_NewsReleaseCompanyLogo_93085.jpg

Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment

creativebharatgroup@gmail.com January 10, 2025
Beijing, China & Prague, Czech Republic:   Biocytogen (HKEX: 02315), a global biotech...
Read More Read more about Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion

Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion

creativebharatgroup@gmail.com November 22, 2024
Oslo, November 21st 2024: Lytix Biopharma refers to the release made today...
Read More Read more about Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion
ExxonMobil Announces Licensing Agreement to Expand Proprietary Rebar Processing Technology to Global Markets OG_NewsReleaseCompanyLogo_92259.jpg

ExxonMobil Announces Licensing Agreement to Expand Proprietary Rebar Processing Technology to Global Markets

creativebharatgroup@gmail.com November 3, 2024
Spring, Texas, United States:   ExxonMobil acquires the exclusive overseas licensing rights...
Read More Read more about ExxonMobil Announces Licensing Agreement to Expand Proprietary Rebar Processing Technology to Global Markets